Saturday 7 November 2026
Export DTIL’s income statement to Excel — free account
Precision BioSciences, Inc.
DTIL Healthcare Biotechnology
Precision BioSciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $34.3 million, down 50.1% from fiscal 2024.
- Revenue
- +37,272.4%
- EPS
- +85.0%
- Free cash flow
- −0.52%
- Total debt
- +0.22%
Quarter to September 2026, against a year earlier
10.60
0.73
+7.40%
Follow DTIL
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| (112.69%) | (132.91%) | (69.52%) | (61.52%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
— | — | 2 | 1 | |
| (36.04%) | (44.91%) | (32.50%) | (31.45%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(48.74%) | (61.77%) | (42.69%) | (41.10%) | |
Average Days of Receivables |
— | — | 32.39 | 0.00 | |
Free Cash Flow per Share |
(1.91) | (2.02) | (2.40) | (5.18) | |
Free Cash Flow |
(52.40) | (52.32) | (59.16) | (66.48) | |
Capital Expenditures |
(0.64) | (0.42) | (0.43) | (0.63) | |
| Other line items | |||||
Cash ROIC |
(33.58%) | (33.70%) | (29.62%) | (28.87%) | |
Accounts Receivable Turnover |
— | — | 21.52 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 119.13% | 158.10% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 67.65% | 94.09% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 19.77% | 29.73% | |
Interest Coverage |
(28.56) | (27.55) | (28.36) | (36.67) | |
Operating CF/Net income |
1.34 | 0.98 | 1.35 | 1.44 | |
Depreciation/Fixed assets |
3.21 | 2.45 | 1.93 | 1.45 | |
Capex/Depreciation |
(0.26) | (0.18) | (0.19) | (0.31) | |
Revenue per Share |
0.00 | 0.00 | 1.83 | 2.67 | |
Operating CF per Share |
(1.89) | (2.01) | (2.38) | (5.13) | |
Capex per Share |
(0.02) | (0.02) | (0.02) | (0.05) | |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.02 |
Columns are period end dates · fundamentals updated 5 Nov 2026